GE Healthcare Technologies Inc (NASDAQ:GEHC) reported first-quarter sales of $4.6 billion, down 1% Y/Y, and were approximately flat on an Organic basis, with decreased volume partially offset by positive price, missing the consensus of $4.8 billion. Net income attributable to GE HealthCare was $374 million versus $372 million for the prior year, and Adjusted EBIT was $681 million versus $664 million. Total company book-to-bill was at 1.03 times, defined as Total orders divided by Total revenues. Total company orders increased by 1% organically year-over-year. The company posted an adjusted EPS ...